Table 3

Differences† in mean biomarker levels in KYH vs Tromsø 7 adjusted for CVD risk factors

NModel 1 (adjusted for age)Model 2 (adjusted for age, smoking, BMI, WHR, SBP, DBP, diabetes, education)Model 3 (adjusted for age, smoking, BMI, WHR, SBP, DBP, diabetes, education, lipid-lowering drugs)
Men
Total cholesterol9669−0.22 (−0.29, −0.1)−0.31 (−0.39, −0.19)−0.30 (−0.38, −0.17)
HDL9669−0.05 (−0.07, −0.02)−0.05 (−0.07, −0.02)−0.05 (−0.07, −0.02)
LDL9679−0.26 (−0.34, −0.22)−0.32 (−0.41, −0.28)−0.31 (−0.39, −0.27)
Triglycerides‡§94540.03 (0.00, 0.07)0.02 (−0.01, 0.06)0.02 (−0.01, 0.06)
hsCRP‡96690.29 (0.23, 0.35)0.16 (0.10, 0.22)0.17 (0.11, 0.22)
NT-proBNP‡21920.44 (0.36, 0.53)0.37 (0.27, 0.47)0.37 (0.27, 0.46)
hs-cTnT‡21970.36 (0.31, 0.40)0.37 (0.32, 0.42)0.37 (0.32, 0.42)
Women
Total cholesterol11 189−0.07 (−0.15, 0.04)−0.13 (−0.21, −0.01)−0.09 (−0.17, 0.03)
HDL11 189−0.13 (−0.16, −0.11)−0.02 (−0.04, 0.01)−0.02 (−0.04, 0.01)
LDL11 189−0.03 (−0.10, 0.01)−0.13 (−0.21, −0.09)−0.09 (−0.17, −0.05)
Triglycerides‡10 8590.10 (0.07, 0.12)0.03 (0.00, 0.06)0.03 (0.00, 0.06)
hsCRP‡11 1890.31 (0.26, 0.35)0.04 (−0.01, 0.10)0.05 (0, 0.11)
NT-proBNP‡28760.27 (0.21, 0.33)0.33 (0.25, 0.39)0.32 (0.24, 0.38)
hs-cTnT‡28800.52 (0.48, 0.55)0.49 (0.45, 0.53)0.49 (0.45, 0.53)
  • †Values in KYH minus those in Tromsø 7 and 95% CIs, all models based on cases without missing data on adjustment variables.

  • ‡Analysis is based on ln-transformed values.

  • §The models for triglycerides were additionally adjusted for fasting time because of differences in mean fasting time in the two studies. Fasting time was recorded from participants' self-report.

  • BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; HDL, high-density lipoprotein, hsCRP, high-sensitivity C-reactive protein; hs-cTnT, high-sensitivity cardiac troponin T; KYH, Know Your Heart; LDL, low-density lipoprotein; NT-proBNP, N-terminal pro-b-type natriuretic peptide; systolic blood pressure; WHR, waist-to-hip ratio.